美股A股
StockGist
Back
10-K2026-03-26· deepseek-chat

VATE · INNOVATE Corp.

0001006837-26-000014

SEC filing

Summary

INNOVATE Corp. reported revenue of $1.25 billion for FY 2025, generating gross profit of $199.7 million. Despite positive operating income of $28.7 million, the company incurred a net loss of $64.0 million, primarily due to high interest expense of $89.0 million. The net loss attributable to common stockholders was $64.0 million, with loss per share of $5.00. The company maintained strong operating cash flow of $146.6 million, ending with $112.1 million in cash and cash equivalents. Total assets stood at $950.1 million against total liabilities of $1.17 billion, resulting in stockholders' deficit of $226.2 million. The company operates through three reportable segments: Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum (Broadcasting).

Key takeaways

Full analysis

Performance Summary

INNOVATE Corp. reported revenue of $1.25 billion for fiscal year 2025, with gross profit of $199.7 million representing a 16.0% gross margin. The company generated operating income of $28.7 million, but significant interest expense of $89.0 million resulted in a loss from operations before income taxes of $61.5 million. After income tax expense of $2.5 million, the company reported a net loss of $64.0 million. The net loss attributable to common stockholders was $64.0 million, with loss per share of $5.00 based on 13.2 million weighted-average common shares outstanding. The company's operating cash flow of $146.6 million was strong despite the net loss, driven by working capital improvements including $48.7 million from accounts receivable and $57.1 million from accounts payable.

Revenue Analysis

The company operates through three reportable segments: Infrastructure (DBMG), Life Sciences (Pansend), and Spectrum (Broadcasting), plus an Other segment for businesses that do not meet separately reportable segment thresholds. DBMG provides fully integrated structural and steel construction services, Pansend focuses on supporting healthcare and biotechnology product development, and Broadcasting operates Over-The-Air broadcasting stations across the United States including Puerto Rico. The document does not disclose specific revenue figures for individual segments, geographic breakdowns, or year-over-year growth rates for segment performance.

Margins & Profitability

The company achieved a gross margin of 16.0% on revenue of $1.25 billion with cost of revenue of $1.05 billion. Operating expenses included selling, general and administrative expenses of $153.1 million and depreciation and amortization of $17.5 million. The operating margin was 2.3% based on operating income of $28.7 million. High interest expense of $89.0 million was the primary driver of the net loss position, along with loss from equity investees of $5.9 million, partially offset by other income, net of $4.7 million. The company's effective tax rate cannot be calculated from the disclosed figures as the pre-tax loss of $61.5 million and tax expense of $2.5 million represent a negative effective rate.

Cash Flow & Balance Sheet

The company generated $146.6 million in cash from operating activities, with key adjustments including depreciation and amortization of $30.4 million and amortization of deferred financing costs and debt discount of $23.7 million. Investing activities used $22.6 million primarily for purchase of property, plant and equipment of $26.1 million. Financing activities used $61.2 million including net payments on lines of credit of $30.9 million and principal payments on other debt obligations of $48.7 million. Free cash flow (operating cash flow minus capital expenditures) was $124.0 million. The balance sheet shows total assets of $950.1 million including current assets of $451.5 million. Total liabilities were $1.17 billion including current liabilities of $1.03 billion and current portion of debt obligations of $581.4 million. Stockholders' deficit was $226.2 million with accumulated deficit of $582.5 million.

Outlook

The company faces substantial doubt about its ability to continue as a going concern and has high levels of indebtedness with restrictive covenants in debt and preferred stock instruments. The company's principal source of cash is distributions from subsidiaries, which may be limited by law and contractual restrictions. Specific debt obligations include $360.4 million aggregate principal amount of 10.50% 2027 Senior Secured Notes, $53.5 million aggregate principal amount of 9.50% 2027 Convertible Notes, and a $20.0 million secured revolving credit agreement with $20.0 million drawn as of December 31, 2025. The company must meet working capital and long-term liquidity requirements while managing restrictive covenants that may require disposal of material assets or operations to meet obligations. No specific financial guidance or forward-looking projections are provided in the document content.